General Information |
Description |
In this trial of retinal pigment epithelium (RPE) replacement, the aim will be to evaluate the safety and feasibility/efficacy of treating subjects with exudative age-related macular degeneration (AMD) by transplanting autologous iPSC derived RPE sheets. |
Clinical trials phase |
Other |
Start date (estimated) |
2013-10-02 |
End date (estimated) |
2019-02-28 |
Clinical feature |
Label |
age related macular degeneration |
Link |
http://purl.obolibrary.org/obo/DOID_10871 |
Description |
A degeneration of macula and posterior pole that is characterized by a loss of vision in the center of the visual field (the macula) resulting from damage to the retina and resulting in blurring of the sharp central vision.; OMIM mapping confirmed by DO. [SN]. |
|
Publications |
|
Administrative Information |
ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=JPRN-UMIN000011929 |
Other study identifiers |
Name |
UMIN000011929 |
Description |
UMIN Clinical Trials Registry (UMIN-CTR) |
|
Source weblink |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013279 |
Public contact |
Email |
hirami@fbri.org |
First name |
Yasuhiko |
Last name |
Hirami |
Phone |
078-302-4321 |
City |
Kobe |
Country |
|
Address freetext |
Kobe City Medical Center General Hospital |
|
Sponsors |
Riken |
Cells |
Which differentiated cell type is used |
Label |
retinal pigment epithelial cell |
Link |
http://purl.obolibrary.org/obo/CL_0002586 |
Description |
An epithelial cell of the retinal pigmented epithelium. |
|
Recruitment |
Recruitment Status |
Completed |
Comment recruitment status |
The trial was halted after two patients because of Japan's Regenerative Medicine Law of 2014. (Estimated number of participants was 6). |
Estimated number of participants |
2 |